|
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Key: Meeting
Showing releases 76-100 out of 496. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>
Public Release: 2-Oct-2012
Frontiers in Optics 20123-D medical scanner: New handheld imaging device to aid doctors on the 'diagnostic front lines' Engineers have created a new imaging tool for primary care physicians: a handheld scanner that would enable them to image all the sites they commonly examine--such as inner ears or the health of patients' retinas. The device relies on optical coherence tomography and could offer sooner and better diagnoses for common conditions such as diabetes. The team will present their findings at the Optical Society's Annual Meeting, Frontiers in Optics 2012. Contact: Angela Stark
Public Release: 2-Oct-2012
WHO prequalifies a new artemisinin-based combination treatment for malaria Cipla, one of the leading generic pharmaceutical companies, along with the non-profit research and development organization Drugs for Neglected Diseases initiative today announced the prequalification of the fixed dose combination of Artesunate and Mefloquine – ASMQ FDC – by the World Health Organization. This Cipla-manufactured ASMQ FDC is the first artesunate-mefloquine FDC to be prequalified by WHO and is recommended for the treatment of malaria. Contact: Violaine Dällenbach
Public Release: 2-Oct-2012
 PLOS MedicineObesity and under-nutrition prevalent in long-term refugees living in camps A quarter of households in refugee camps in Algeria are currently suffering from the double burden of excess weight and under-nutrition. According to a study published in the journal PLOS Medicine, obesity is an emerging threat to this community, with one in two women of childbearing age being overweight, whilst nutritional deficiencies such as iron-deficiency anemia and stunted growth remain a persistent problem. 
European Community Humanitarian Office, UNHCR, UN
Contact: David Weston
Public Release: 2-Oct-2012
PLOS MedicineA national mental health policy for Uganda In another installment of the PLOS Medicine series on Global Mental Health Practice, Joshua Ssebunnya from the Butabika National Referral and Teaching Mental Hospital in Kampala and colleagues describe their work developing a national mental health policy for Uganda. Contact: Sumrina Yousufzai
Public Release: 2-Oct-2012
PLOS MedicineBoth obesity and under-nutrition affect long-term refugee populations Both obesity and under-nutrition are common in women and children from the Western Sahara living in refugee camps in Algeria, highlighting the need to balance both obesity prevention and management with interventions to tackle under-nutrition in this population, according to a study by international researchers published in this week's PLOS Medicine. Contact: Sumrina Yousufzai
Public Release: 27-Sep-2012
PLOS PathogensGenetic sleuthing uncovers deadly new virus in Africa An isolated outbreak of a deadly disease known as acute hemorrhagic fever, which killed two people and left one gravely ill in the Democratic Republic of Congo in the summer of 2009, was probably caused by a novel virus scientists have never seen before. Contact: Jason Socrates Bardi
Public Release: 27-Sep-2012
Controlling the spread of diseases among humans, other animals and the environment West Nile virus, Lyme disease and hantavirus are all infectious diseases spreading in animals and in people. Is human interaction with the environment somehow responsible for the increase in incidence of these diseases? Contact: Cheryl Dybas
Public Release: 27-Sep-2012
International Journal of Critical Infrastructures Sandia probability maps help sniff out food contamination Uncovering the sources of fresh food contamination could become faster and easier thanks to analysis done at Sandia National Laboratories' National Infrastructure Simulation and Analysis Center (NISAC).
Department of Homeland Security
Contact: Stephanie Holinka
Public Release: 27-Sep-2012
LancetStudy highlights the burden of epilepsy in the developing world The burden of epilepsy in poorer parts of the world could be readily alleviated by reducing the preventable causes and improving access to treatment, according to a review article funded by the Wellcome Trust.
Wellcome Trust
Contact: Jen Middleton
Public Release: 26-Sep-2012
GW receives record 5-year, $134 million grant to study type 2 diabetes medications John Lachin, professor of biostatistics, epidemiology and statistics at the George Washington University, has been awarded a five-year, $134 million grant from the National Institute of Health's National Institute of Diabetes and Digestive and Kidney Diseases to conduct a clinical trial examining the long-term effectiveness of several glucose-lowering medications for treatment of people with type 2 diabetes. The grant sets a record as the largest sum award GW has ever received.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Contact: Latarsha Gatlin
Public Release: 25-Sep-2012
PLOS MedicinePLOS Medicine editors comment on progress of World Health Report 2012 In this month's editorial, the PLOS Medicine Editors comment on the World Health Organization's (WHO) latest World Health Report, originally planned for publication in 2012, and the outcomes of the journal's collaboration with WHO on the intended theme of "no health without research." Contact: Sumrina Yousufzai
Public Release: 25-Sep-2012
PLOS MedicineLarge donors are forcing the World Health Organization to reform The current practice of large donors is forcing the World Health Organization and the World Bank to reflect on how to reform to remain more appealing to the wider set of stakeholders and interests at play, according to Devi Sridhar from the University of Oxford writing in this week's PLOS Medicine. Contact: Sumrina Yousufzai
Public Release: 24-Sep-2012
World Heart Federation says heart health starts earlier than you think A new multi-national survey reveals the extent of misconceptions about when is the right time to start taking action to prevent cardiovascular disease. In a four-country survey sample of 4,000 adults, 49 percent answered age 30 years or older when asked at what age they believe people should start to take action about their heart health to prevent conditions such as heart disease and stroke. Contact: Charanjit K. jagait
Public Release: 23-Sep-2012
International Congress for Tropical Medicine and MalariaBrazil, FIOCRUZ and DNDi Latin America partner to fight neglected diseases At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation and the Drugs for Neglected Diseases initiative Latin America, uniting the three actors into a strategic partnership to collaborate on research and development for new therapies and diagnostics for neglected diseases. Contact: Mariana Abdalla
Public Release: 20-Sep-2012
$20 million gift launches new hub for global health at UCSF The University of California, San Francisco has received a $20 million gift from philanthropist Chuck Feeney to build a new hub for Global Health Sciences at the UCSF Mission Bay campus. Feeney made the gift through The Atlantic Philanthropies, the foundation he created in 1982. Contact: Kristen Bole
Public Release: 20-Sep-2012
ScienceNew strategies needed to combat disease in developing countries So-called lifestyle diseases are gaining ground with epidemic speed in low-income countries. The traditional health focus in these countries has been to combat communicable diseases such as malaria, HIV and tuberculosis. However, research from the University of Copenhagen suggests that dividing campaigns into combating either non-communicable or communicable diseases is ineffective and expensive. A new article by Danish scientists published in the well-reputed journal Science provides an overview. Contact: Professor Ib Bygbjerg
Public Release: 20-Sep-2012
Sanofi and TB Alliance announce collaboration to accelerate new tuberculosis treatments Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis, a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010. Under the agreement, Sanofi and TB Alliance will collaborate to further optimize and develop several novel compounds in Sanofi's library that have demonstrated activity against Mycobacterium tuberculosis, the bacterium that causes TB. Contact: Derek Ambrosino
Public Release: 19-Sep-2012
Science Translational MedicineBIDMC and Diagnostics For All create first low-cost, paper-based, point of care liver function test A new postage stamp-sized, paper-based device could provide a simple and reliable way to monitor for liver damage at a cost of only pennies per test, say researchers at Beth Israel Deaconess Medical Center (BIDMC) and Diagnostics For All (DFA), a Cambridge, MA nonprofit dedicated to improving the health of people living in the developing world.
Department of Defence, National Institutes of Health, Gates Foundation
Contact: Kelly Lawman
Public Release: 19-Sep-2012
NeuronAutism symptoms could arise from unreliable neural responses Diverse symptoms associated with autism could be explained by unreliable activity of neurons in the brain in response to basic, nonsocial sensory information, according to a study published by Cell Press on September 19th in the journal Neuron. The new findings suggest that autism is a disorder of general neural processing and could potentially provide an explanation for the origins of a range of psychiatric and neurological disorders. Contact: Elisabeth (Lisa) Lyons
Public Release: 17-Sep-2012
Diabetes CareRisk of developing diabetes higher in neighborhoods that aren't walk-friendly: Study Whether your neighborhood is conducive to walking could determine your risk for developing diabetes, according to a new study by researchers at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences. Contact: Kate Taylor
Public Release: 17-Sep-2012
EMBO Molecular MedicineScientists reveal how natural antibiotic kills tuberculosis bacterium A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works. This promising drug candidate is active against many of the drug-resistant types of the tuberculosis bacterium that no longer respond to treatment with the front-line drug isoniazid. Contact: Barry Whyte
Public Release: 13-Sep-2012
UCLA's Aydogan Ozcan lauded as one of world's most brilliant innovators by Popular Science Popular Science magazine has named Aydogan Ozcan, an associate professor of electrical engineering and bioengineering at UCLA, one of the world's "Brilliant 10" scientists in its October 2012 issue. Contact: Matthew Chin
Public Release: 13-Sep-2012
Journal of Biological ChemistryMutation breaks HIV's resistance to drugs The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called 172K, made certain forms of the virus more susceptible to treatment. Soon, doctors will be able to use this knowledge to improve the drug regiment they prescribe to HIV-infected individuals. Contact: Tim Wall
Public Release: 13-Sep-2012
Journal of American Chemical SocietyIU chemist develops new synthesis of most useful, yet expensive, antimalarial drug In 2010 malaria caused an estimated 665,000 deaths, mostly among African children. Now, chemists at Indiana University have developed a new synthesis for the world's most useful antimalarial drug, artemisinin, giving hope that fully synthetic artemisinin might help reduce the cost of the live-saving drug in the future.
Indiana University
Contact: Steve Chaplin
Public Release: 13-Sep-2012
PLOS PathogensScripps Research scientists reveal how deadly virus silences immune system Scientists at The Scripps Research Institute have determined the structure of a critical protein from the Marburg virus, a close cousin of Ebola virus. These viruses cause similar diseases and are some of the deadliest pathogens on the planet, each killing up to 90 percent of those infected.
Burroughs Wellcome Fund, Skaggs Institute for Chemical Biology at The Scripps Research Institute
Contact: Mika Ono
Showing releases 76-100 out of 496. << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 > >>
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||
|
|
 |
|
